Half Year Results 

Smiths hits pause on demerger

Smiths hits pause on demerger

Engineering conglomerate Smiths (SMIN) finds itself in a rather peculiar situation. The Covid-19 pandemic is driving uncertainty across much of its operations, but has created the perfect conditions for its medical business, architect of the now sought-after paraPac ventilator. Unfortunately, the Smiths Medical division is currently classified as discontinued pending a demerger that has been put on hold.

To continue reading, subscribe today

and enjoy unlimited access to the following:

  • Tips of the Week
  • Funds coverage
  • Weekly features on big investment themes
  • Trading ideas
  • Comprehensive companies coverage
  • Economic analysis
Subscribe
Subscribe to Investors Chronicle

Subscribe today

Full access for just £3.37 a week:

• Tips and recommendations - to beat the market 
• Portfolio clinic & Mr Bearbull - build a well-planned portfolio 
• Expert tools - track and manage investments effortlessly
• Plus free delivery to your home or office

Subscribe Now